247 related articles for article (PubMed ID: 11350522)
1. Treatment outcome for IDDM patients in relation to glutamic acid decarboxylase autoantibodies and serum IgG to periodontal pathogens.
Sims TJ; Lernmark A; Smith T; Page RC; Persson GR
J Clin Periodontol; 2001 Jun; 28(6):550-7. PubMed ID: 11350522
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis.
Sims TJ; Lernmark A; Mancl LA; Schifferle RE; Page RC; Persson GR
J Clin Periodontol; 2002 Jun; 29(6):551-62. PubMed ID: 12296783
[TBL] [Abstract][Full Text] [Related]
3. Short-term responses to periodontal therapy in insulin-dependent diabetic patients.
Smith GT; Greenbaum CJ; Johnson BD; Persson GR
J Periodontol; 1996 Aug; 67(8):794-802. PubMed ID: 8866319
[TBL] [Abstract][Full Text] [Related]
4. IgG sera levels against a subset of periodontopathogens and severity of disease in aggressive periodontitis patients: a cross-sectional study of selected pocket sites.
Saraiva L; Rebeis ES; Martins Ede S; Sekiguchi RT; Ando-Suguimoto ES; Mafra CE; Holzhausen M; Romito GA; Mayer MP
J Clin Periodontol; 2014 Oct; 41(10):943-51. PubMed ID: 25070874
[TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis.
Lamster IB; Kaluszhner-Shapira I; Herrera-Abreu M; Sinha R; Grbic JT
J Clin Periodontol; 1998 Jun; 25(6):510-6. PubMed ID: 9667485
[TBL] [Abstract][Full Text] [Related]
6. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia.
Choi YH; McKeown RE; Mayer-Davis EJ; Liese AD; Song KB; Merchant AT
J Periodontol; 2014 Sep; 85(9):1172-81. PubMed ID: 24410292
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG antibody response to periodontal pathogens in minority populations: relationship to periodontal disease status and progression.
Craig RG; Boylan R; Yip J; Mijares D; Imam M; Socransky SS; Taubman MA; Haffajee AD
J Periodontal Res; 2002 Apr; 37(2):132-46. PubMed ID: 12009183
[TBL] [Abstract][Full Text] [Related]
8. Serum antibodies reacting with subgingival species in refractory periodontitis subjects.
Colombo AP; Sakellari D; Haffajee AD; Tanner A; Cugini MA; Socransky SS
J Clin Periodontol; 1998 Jul; 25(7):596-604. PubMed ID: 9696261
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction.
van Winkelhoff AJ; Loos BG; van der Reijden WA; van der Velden U
J Clin Periodontol; 2002 Nov; 29(11):1023-8. PubMed ID: 12472995
[TBL] [Abstract][Full Text] [Related]
10. Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus.
Takahashi K; Nishimura F; Kurihara M; Iwamoto Y; Takashiba S; Miyata T; Murayama Y
J Int Acad Periodontol; 2001 Oct; 3(4):104-11. PubMed ID: 12666949
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass specific antibody response to periodontopathic organisms in HIV-positive patients.
Yeung SC; Taylor BA; Sherson W; Lazarus R; Zhao ZZ; Bird PS; Hamlet SM; Bannon M; Daly C; Seymour GJ
J Periodontol; 2002 Dec; 73(12):1444-50. PubMed ID: 12546094
[TBL] [Abstract][Full Text] [Related]
12. Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.
Horibe M; Watanabe H; Ishikawa I
J Clin Periodontol; 1995 Jul; 22(7):510-5. PubMed ID: 7560233
[TBL] [Abstract][Full Text] [Related]
13. A comparison of IgG antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and early-onset periodontitis.
Califano JV; Gunsolley JC; Schenkein HA; Tew JG
J Periodontol; 1997 Aug; 68(8):734-8. PubMed ID: 9287063
[TBL] [Abstract][Full Text] [Related]
14. Effect of initial therapy on dynamics of immunogloblin G levels to some periodontopathic bacteria in serum and gingival crevicular fluid.
Hosaka Y; Saito A; Nakagawa T; Seida K; Yamada S; Okuda K
Bull Tokyo Dent Coll; 1994 Nov; 35(4):207-16. PubMed ID: 8689734
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to periodontal pathogens and stroke risk.
Pussinen PJ; Alfthan G; Rissanen H; Reunanen A; Asikainen S; Knekt P
Stroke; 2004 Sep; 35(9):2020-3. PubMed ID: 15232116
[TBL] [Abstract][Full Text] [Related]
16. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
Rams TE; Listgarten MA; Slots J
J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in humans 1 year after 4 randomized treatment modalities.
Shiloah J; Patters MR; Dean JW; Bland P; Toledo G
J Periodontol; 1998 Dec; 69(12):1364-72. PubMed ID: 9926766
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.
Trindade SC; Gomes-Filho IS; Meyer RJ; Vale VC; Pugliese L; Freire SM
J Int Acad Periodontol; 2008 Apr; 10(2):50-8. PubMed ID: 18564729
[TBL] [Abstract][Full Text] [Related]
19. Evidence for local production of antibodies to auto and non-self antigens in periodontal disease.
Rajapakse PS; Dolby AE
Oral Dis; 2004 Mar; 10(2):99-105. PubMed ID: 14996280
[TBL] [Abstract][Full Text] [Related]
20. The survival rate of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus following 4 randomized treatment modalities.
Shiloah J; Patters MR; Dean JW; Bland P; Toledo G
J Periodontol; 1997 Aug; 68(8):720-8. PubMed ID: 9287061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
